Phase 3 Trials Drug Trials Semaglutide Randomized Trials Ketamine Comparative Studies UK-Wide Trial Drug Development Vaccine Efficacy Therapeutic Strategies Antibody Therapy Substance Abuse Children Cardiovascular Disease Blood Biomarker Challenge Pivya Effectiveness Mouse Models Antibiotic Treatments
New research reveals Borrelia burgdorferi peptidoglycan lingers in human tissues, triggering chronic inflammation and opening pathways for targeted therapies.